Benralizumab continues to improve quality of life after 6 months of treatment in Canadians with severe eosinophilic asthma Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Penz, E
  • Kayaniyil, S
  • Lancaster, B
  • Francoeur, B
  • Lee, JK
  • Mallet, M
  • Tourin, O
  • Ramesh, W
  • Mahdavian, M
  • Walker, BL
  • Belak, Z
  • Thawer, A
  • Dhawan, V
  • Mbuagbaw, Lawrence
  • Noorduyn, SG

publication date

  • September 4, 2022